Actively Recruiting
Smartphones for Opiate Addiction Recovery
Led by NYU Langone Health · Updated on 2026-02-27
225
Participants Needed
2
Research Sites
291 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing illicit opiate use during treatment has thus recently become a major NIDA policy goal. The 5-minute battery indicates the numerical probability that a patient will reuse illicit opiates within the next 7-10 days.
CONDITIONS
Official Title
Smartphones for Opiate Addiction Recovery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Meet DSM-5 criteria for opioid-use disorder (heroin and/or prescription opioids)
- Entered or planning to enter OUD treatment with methadone or buprenorphine
- Any gender
- Age 18 years or older
- Used opioids not as prescribed within 30 days before consent
- In generally good health
- Able to provide written informed consent
- Able to speak English well enough to understand study procedures
- Licensed MD treating OUD with methadone or buprenorphine at study site (for physician participants)
- Licensed MSW, NP, or MD treating OUD but not part of study treatment team (for clinician participants)
You will not qualify if you...
- Serious medical or psychiatric conditions that make participation unsafe or incomplete
- Severe untreated mental disorders like active psychosis or uncontrolled bipolar illness
- Current severe use of alcohol, benzodiazepines, or other sedatives requiring complex detox
- Suicidal or homicidal thoughts needing immediate care
- Severe pain requiring ongoing opioid management
- Pending legal issues that may prevent study completion
- Pregnancy or breastfeeding
- Prisoners or individuals in residential court-ordered substance abuse treatment
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Rutgers University
Piscataway, New Jersey, United States, 08854
Not Yet Recruiting
2
NYU Langone
New York, New York, United States, 10016
Actively Recruiting
Research Team
P
Paul Glimcher
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
FACTORIAL
Primary Purpose
TREATMENT
Number of Arms
5
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here